Richtlijn CVRM feb2013 - KNMP

safety of dabigatran compared with warfarin at different levels of international normalised
ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial. Lancet
2010; 376 (9745): 975-83.
Warle 2012
Warle-Herwaarden MF, Roukens M, Pop GAM, Lamfers EJP, De Smet PAGM, Kramers C. Adherence tot
guidelines for the prescribing of double and triple combinations of anti-thrombotic agents. European
J of preventive cardiology 2012; Published online before print June 8, 2012,
doi:10.1177/2047487312451253..
Warlow 1992 Warlow CP. Secondary prevention of stroke. Lancet 1992; 339: 724-727.
Wassmann 2001 Wassmann S, Laufs U, Baumer AT, Muller K, Konkol C, Sauer H, et al. Inhibition of
geranylgeranylation reduces angiotensin II-mediated free radical production in vascular
smooth muscle cells: involvement of angiotensin ATI receptor expression and RacI GTPase.
Pharmacol 2001; 59: 646-54.
Mol
Weber 2005
Weber MA. Managing the patient at risk for a second stroke. J Hypertens Suppl. 2005;23:S41-7.
Weng 2010 Weng TC, kao Yang YH, Lin SJ, Tai SH. A systematich review and meta-analysis on the
therapeutic equivalence of statins., Journal of Clin Pharmacy and Therapeutics 2010; 35: 139- 151.
Werkum v 2008 Werkum van JW, Witte OA, ten Berg JM, Verheugt FWA. Late coronaire stenttrombose als complicatie
van drug-eluting stents. Hart Bulletin 2008, 39 (nr 1): 4-9.
Westerweel 2004 Westerweel PE, Verhaar MC, Rabelink TJ. Pleiotrope effecten van statinen. NTVG 2004; 148
(29): 1431-1435.
Westover 2011 Westover MB., Bianchi MT, Eckman MH, Greenberg SM. Statin Use following Intracerebral
Hemorrhage. A decision Analysis. Arch Neurol 2011; 68 (5): 573-579.
Wiersma 2004
Wiersma 2008
Wiersma Tj, Verduijn M, Bouma M, Goudswaard AN. Indicatie voor een bètablokker Kies voortaan
metoprolol! Huisarts en Wetenschap 2004; 47: 651.
Wiersma Tj, Verduijn MM, Bouma M, Goudswaard AN. NHG houdt voorkeur voor metoprolol. Huisarts
Wet 2008;51(6):283-6.
Winkel 2010 Winkel TA, Schouten O, Voute MT, Hoeks SE, Welten GM, Bax JJ et al. The effect of statins op
perioperatieve events in patients undergoing vascualr surgery. Acta Chir Belg 2010; 110 (1): 28-
31.
Witteman 1994 Witteman JCM, Grobbee DE, Valkenburg HA, van Hemert AM, Stijnen T, Burger H et al. J-
shaped relation between change in diastolic blood pressure and progression of aortic
atherosclerosis. Lancet 1994; 343: 504-507.
Wiviott 2007
Wiviott SD, Braunwald E, Mc Cabe CH, et al. Prasugrel versus clopidogrel in patients with acute
coronary syndromes. N Eng J Med 2007; 357: 2001-15
Wiviott 2008 Wiviott SD, Braunwald E, McCabe CH, Horvath I, Keltai M, Herrman JP. Et al. TRITON-TIMI 38
Investigators. Intensive oral antiplatelet therapy for reduction of ischaemic events including stent
thrombosis in patients with acute coronary syndromes treated with percutaneous coronary
intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial. Lancet.
2008 Apr 19;371(9621):1353-63.
Wiviott 2009
Wiysonge 2007
Wiviott SD, Trenk D, Frelinger AL, et al. Prasugrel compared with hihg loading- and maintenancedose
clopidogrel in patinetns with planned percutaneous coronayr intervention. Eur Heart J, 2009;
30: 916-22.
Wiysonge CS, Bradley H, Mayosi BM, Maroney R, Mbewu A, Opie LH, Volmink J. Beta-blockers for
hypertension. The Cochrane Library, Issue 1, 2007. Chichester: Wiley.
Wolowacz 2009 Wolowacz SE, Roskell NS, Plumb JM, Caprini JA, Eriksson BI. Efficacy and safety of dabigatran
etexilate for the prevention of venouw thromboembolism following Total hip or knee
arthroplasty. A meta analysis. Thromb Haemost 2009; 101 (1); 77-85.
101
CONCEPT